Ref‐1 redox activity regulates retinal neovascularization by modulating transcriptional activation of HIF ‐1α
The FASEB Journal · 2025
DOI: 10.1096/fj.202401989rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Gabriella D Hartman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Retinal Neovascularization, Hypoxia-Inducible Factor 1, alpha Subunit, DNA-(Apurinic or Apyrimidinic Site) Lyase, Transcriptional Activation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: HHS | NIH | National Eye Institute (NEI), Tom Wood Lexus Foundation, HHS | NIH | National Cancer Institute (NCI).
Abstract (Originalsprache)
Retinal neovascularization impairs visual function and is a hallmark of several neovascular eye diseases, including retinopathy of prematurity (ROP) and proliferative diabetic retinopathy (PDR). Current treatments include intravitreal injections of anti‐vascular endothelial growth factor (VEGF) biologics, but these therapeutics are often accompanied by high treatment burden and resistance to therapy. Prior studies indicate that APE1/Ref‐1, a multifunctional protein with both endonuclease (APE1) and redox‐mediated transcriptional regulatory activity (Ref‐1), activates multiple pro‐angiogenic and pro‐inflammatory signaling pathways by chemically reducing key cysteine residues in transcription factors, thereby activating them. Here, we investigated the previously unexplored role of Ref‐1 in retinal neovascularization. We demonstrate that Ref‐1 is highly expressed in endothelial cells in human PDR and in the oxygen‐induced retinopathy (OIR) mouse model of retinal neovascularization. Ref‐1 is also highly expressed in microglia and astrocytes in OIR. A small molecule Ref‐1 redox inhibitor, APX2009, decreased retinal neovascularization in OIR after systemic delivery. In vitro, hypoxic endothelial cells did not exhibit upregulation of Ref‐1 but rather increased Ref‐1 nuclear localization. APX2009 decreased hypoxic endothelial cell proliferation and HIF‐1α transcriptional activation. Thus, Ref‐1 redox activity may be a novel therapeutic target for the treatment of retinal neovascularization, making APX2009 a promising systemic therapeutic approach for the treatment of vascular retinopathies such as ROP and PDR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
- Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Indiana University Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.
ORCID-Profile: Gabriella D Hartman, Anbukkarasi Muniyandi, Kamakshi Sishtla, Eyram K Kpenu, William P Miller, Bryan A Kaplan, Leo A Kim, Sheng Liu, Jun Wan, Xiaoping Qi, Michael E Boulton, Mark R Kelley, Timothy W Corson
Förderung
- HHS | NIH | National Eye Institute (NEI)
- Tom Wood Lexus Foundation
- HHS | NIH | National Cancer Institute (NCI)
- NCI NIH HHS
- Research to Prevent Blindness (RPB)
- Riley Children's Foundation (RCF)
- NEI NIH HHS
- Canada Foundation for Innovation (CFI)
Zitieren
APA
Hartman, G. D., Muniyandi, A., Sishtla, K., Kpenu, E. K., Miller, W. P., Kaplan, B. A., Kim, L. A., Liu, S., Wan, J., Qi, X., Boulton, M. E., Kelley, M. R., & Corson, T. W. (2025). Ref‐1 redox activity regulates retinal neovascularization by modulating transcriptional activation of HIF ‐1α. The FASEB Journal. https://doi.org/10.1096/fj.202401989rr
Vancouver
Hartman GD, Muniyandi A, Sishtla K, Kpenu EK, Miller WP, Kaplan BA, et al. Ref‐1 redox activity regulates retinal neovascularization by modulating transcriptional activation of HIF ‐1α. The FASEB Journal. 2025. doi:10.1096/fj.202401989rr
BibTeX
@article{Hartman2025,
author = {Hartman, Gabriella D and Muniyandi, Anbukkarasi and Sishtla, Kamakshi and Kpenu, Eyram K and Miller, William P and Kaplan, Bryan A and Kim, Leo A and Liu, Sheng and Wan, Jun and Qi, Xiaoping and Boulton, Michael E and Kelley, Mark R and Corson, Timothy W},
title = {Ref‐1 redox activity regulates retinal neovascularization by modulating transcriptional activation of HIF ‐1α},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202401989rr}
}
EUVIMED